Patents by Inventor Daniel A. Snyder

Daniel A. Snyder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GAS TURBINE ENGINE COMPONENT HAVING ENGINEERED VASCULAR STRUCTURE
    Publication number: 20160076384
    Abstract: A component according to an exemplary aspect of the present disclosure includes, among other things, a wall and a hollow vascular engineered lattice structure formed inside of the wall. The hollow vascular engineered lattice structure has an inlet hole and an outlet hole that communicate fluid into and out of the hollow vascular structure. The hollow vascular engineered lattice structure further has at least one resupply inlet hole between the inlet hole and the outlet hole to communicate additional fluid into the hollow vascular engineered lattice structure.
    Type: Application
    Filed: November 23, 2015
    Publication date: March 17, 2016
    Inventors: Daniel A. Snyder, Tracy A. Propheter-Hinckley, Dominic J. Mongillo
  • Heterocyclic compounds and uses thereof
    Patent number: 9255108
    Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: February 9, 2016
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Katrina Chan, Catherine A. Evans, Somarajannair Janardanannair, Andre Lescarbeau, Liansheng Li, Tao Liu, Yi Liu, Pingda Ren, Daniel A. Snyder, Martin R. Tremblay
  • REVERSIBLE BLADE ROTOR SEAL
    Publication number: 20160032751
    Abstract: A rotatable sealing structure for a gas turbine engine includes a first blade and a second blade. A seal is arranged between the blades and has a body that is configured for operative association with the first and second blades in a first orientation and in a second orientation to seal a gap defined between the blades.
    Type: Application
    Filed: July 21, 2015
    Publication date: February 4, 2016
    Inventor: Daniel A. Snyder
  • INHIBITORS OF FATTY ACID AMIDE HYDROLASE
    Publication number: 20150368278
    Abstract: The present invention provides compounds, and pharmaceutically acceptable compositions thereof, encompassed by any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof. The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof.
    Type: Application
    Filed: January 16, 2015
    Publication date: December 24, 2015
    Applicant: INFINITY PHARMACEUTICALS, INC.
    Inventors: Mark L. BEHNKE, Alfredo C. CASTRO, Catherine A. EVANS, Louis GRENIER, Michael J. GROGAN, Tao LIU, Daniel A. SNYDER, Thomas T. TIBBITTS
  • INHIBITORS OF FATTY ACID AMIDE HYDROLASE, METHODS OF TREATMENT AND METHODS OF PREPARING SAME
    Publication number: 20150344503
    Abstract: The present invention provides compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). Methods of preparing compounds encompassed by the formulae (I), (II) or (III) are also provided. The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a provided compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH in a patient by administering a therapeutically effective amount of a compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof.
    Type: Application
    Filed: August 17, 2015
    Publication date: December 3, 2015
    Inventors: Julian Adams, Mark L. Behnke, Alfredo C. Castro, Catherine A. Evans, Louis Grenier, Michael J. Grogan, Tao Liu, Daniel A. Snyder, Thomas T. Tibbitts
  • BLADE ELEMENT CROSS-TIES
    Publication number: 20150322797
    Abstract: A blade element and methods of manufacturing blade elements are provided for blade elements of a gas turbine engine. In one embodiment, a blade element includes a first inner surface of the blade element, wherein the first inner surface is associated with a first outer blade surface of the blade element, and a second inner surface of the blade element, wherein the second inner surface is associated with a second outer blade surface of the blade element and wherein the second inner surface is opposite from the first inner surface. The blade element may also include a cross-tie configured to connect the first inner surface to the second inner surface, wherein the cross-tie is positioned along a trailing edge of the blade element and the cross-tie is configured to reduce vibration mode effects of the blade element.
    Type: Application
    Filed: April 23, 2015
    Publication date: November 12, 2015
    Applicant: United Technologies Corporation
    Inventors: Daniel A. SNYDER, Lane Thornton, Alex J. Simpson
  • Segment matching search system and method
    Patent number: 9158859
    Abstract: A planning and search system are described wherein a graph search and segment matching are used to handle very large searches at a higher speed.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: October 13, 2015
    Assignee: NORTHROP GRUMMAN SYSTEMS CORPORATION
    Inventors: James Daniel Snyder, II, Craig Michael Chase
  • Isoxazolines as inhibitors of fatty acid amide hydrolase
    Patent number: 9149465
    Abstract: The present invention provides isoxazoline FAAH inhibitors of the formula (I): or pharmaceutically acceptable forms thereof, wherein each of G, Ra, Rb, Rc, and Rd are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: October 6, 2015
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Mark L. Behnke, Alfredo C. Castro, Lawrence K. Chan, Catherine A. Evans, Louis Grenier, Michael J. Grogan, Yves Leblanc, Tao Liu, Stephane Peluso, Daniel A. Snyder, Thomas T. Tibbitts
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20150246932
    Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
    Type: Application
    Filed: May 12, 2015
    Publication date: September 3, 2015
    Inventors: Alfredo C. CASTRO, Catherine A. EVANS, Andre LESCARBEAU, Tao LIU, Daniel A. SNYDER, Martin R. TREMBLAY, Pingda REN, Yi LIU, Liansheng LI, Katrina CHAN
  • Substituted isoquinolinones and methods of treatment thereof
    Patent number: 9115141
    Abstract: Substituted isoquinolinone compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: August 25, 2015
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Catherine A. Evans, Somarajannair Janardanannair, Andre Lescarbeau, Tao Liu, Daniel A. Snyder, Martin R. Tremblay, Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan
  • Inhibitors of fatty acid amide hydrolase
    Patent number: 9108989
    Abstract: The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a provided compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH in a patient by administering a therapeutically effective amount of a compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: August 18, 2015
    Assignee: INFINITY PHARMACEUTICALS, INC.
    Inventors: Julian Adams, Mark L. Behnke, Alfredo C. Castro, Catherine A. Evans, Louis Grenier, Michael J. Grogan, Tao Liu, Daniel A. Snyder, Thomas T. Tibbitts
  • Heterocyclic compounds and uses thereof
    Patent number: 9056877
    Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
    Type: Grant
    Filed: July 18, 2012
    Date of Patent: June 16, 2015
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Catherine A. Evans, Andre Lescarbeau, Tao Liu, Daniel A. Snyder, Martin R. Tremblay, Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan
  • METHOD FOR INSPECTING A MANUFACTURING DEVICE
    Publication number: 20150153726
    Abstract: A method is provided for inspecting a plurality of parts with an electronic measurement device and a processing system. The method includes a step of creating surface geometry maps of the parts utilizing the electronic measurement device, where each part was manufactured utilizing the manufacturing device. Geometric part models of the parts are generated from the surface geometry maps. The part models can subsequently be analyzed to determine whether a manufacturing device that manufactured the plurality of parts manufactures parts that comply with a part design specification.
    Type: Application
    Filed: December 18, 2014
    Publication date: June 4, 2015
    Applicant: UNITED TECHNOLOGIES CORPORATION
    Inventors: James Romanelli, IV, Jeffrey S. Beattie, Jesse R. Boyer, Robert E. Erickson, Randall W. Joyner, Daniel A. Snyder, David A. Krause, Kun Tong
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20150126506
    Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
    Type: Application
    Filed: January 8, 2015
    Publication date: May 7, 2015
    Inventors: Alfredo C. CASTRO, Catherine A. EVANS, Somarajannair JANARDANANNAIR, Andre LESCARBEAU, Tao LIU, Daniel A. SNYDER, Martin R. TREMBLAY, Pingda REN, Yi LIU, Liansheng LI, Katrina CHAN
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20150105385
    Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
    Type: Application
    Filed: December 17, 2014
    Publication date: April 16, 2015
    Inventors: Alfredo C. CASTRO, Katrina CHAN, Catherine A. EVANS, Somarajannair JANARDANANNAIR, Andre LESCARBEAU, Liansheng LI, Tao LIU, Yi LIU, Pingda REN, Daniel A. SNYDER, Martin R. TREMBLAY
  • ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE
    Publication number: 20150099738
    Abstract: The present invention provides isoxazoline FAAH inhibitors of the formula (I): or pharmaceutically acceptable forms thereof, wherein each of G, Ra, Rb, Rc, and Rd are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.
    Type: Application
    Filed: June 30, 2014
    Publication date: April 9, 2015
    Inventors: Mark L. BEHNKE, Alfredo C. CASTRO, Lawrence K. CHAN, Catherine A. EVANS, Louis GRENIER, Michael J. GROGAN, Yves LEBLANC, Tao LIU, Stephane PELUSO, Daniel A. SNYDER, Thomas T. TIBBITTS
  • Heterocyclic compounds and uses thereof
    Patent number: 8969363
    Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
    Type: Grant
    Filed: July 18, 2012
    Date of Patent: March 3, 2015
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Catherine A. Evans, Somarajannair Janardanannair, Andre Lescarbeau, Tao Liu, Daniel A. Snyder, Martin R. Tremblay, Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan
  • Inhibitors of fatty acid amide hydrolase
    Patent number: 8957049
    Abstract: The present invention provides compounds, and pharmaceutically acceptable compositions thereof, encompassed by any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof. The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: February 17, 2015
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Mark L. Behnke, Alfredo C. Castro, Catherine A. Evans, Louis Grenier, Michael J. Grogan, Tao Liu, Daniel A. Snyder, Thomas T. Tibbitts
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20150031672
    Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
    Type: Application
    Filed: October 10, 2014
    Publication date: January 29, 2015
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Alfredo C. Castro, Catherine A. Evans, Daniel A. Snyder
  • Method for inspecting a manufacturing device
    Patent number: 8942837
    Abstract: A method is provided for inspecting a plurality of parts with an electronic measurement device and a processing system. The method includes a step of creating surface geometry maps of the parts utilizing the electronic measurement device, where each part was manufactured utilizing the manufacturing device. Geometric part models of the parts are generated from the surface geometry maps. The part models can subsequently be analyzed to determine whether a manufacturing device that manufactured the plurality of parts manufactures parts that comply with a part design specification.
    Type: Grant
    Filed: March 12, 2012
    Date of Patent: January 27, 2015
    Assignee: United Technologies Corporation
    Inventors: James Romanelli, Jeffrey S. Beattie, Jesse R. Boyer, Robert E. Erickson, Randall W. Joyner, Daniel A. Snyder, David A. Krause, Kun Tong